Evidence map›Paper›PMID 33502279›Full record

ArticleRadiology2021

Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties.

Athol U Wells, Anand Devaraj, Sujal R Desai

Registry-linked trialAbstract readEditorialComment
In one paragraph

Article in Radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07380152 (Corticosteroid Treatment for Post-COVID-19 Persistent Interstitial Lung Disease), which is not on this map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07380152 phase1completednot on this map

Corticosteroid Treatment for Post-COVID-19 Persistent Interstitial Lung Disease

TypeinterventionalSponsorUniversity of Sao PauloRan2021 to 2022Enrolled100ConditionsCOVID-19 Pulmonary ComplicationsArmsPrednisolone
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. CT findings in "Post-Covid": residua from acute pneumonia or "Post-Covid-ILD"?Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Athol U WellsFrom the Interstitial Lung Disease Unit (A.U.W.) and Department of Radiology (A.D., S.R.D.), Royal Brompton & Harefield NHS Foundation Trust, Sydney Street, London SW3 6NP, England; and the National Heart and Lung Institute, Imperial College London, London, England (A.U.W., A.D., S.R.D.).
Anand DevarajFrom the Interstitial Lung Disease Unit (A.U.W.) and Department of Radiology (A.D., S.R.D.), Royal Brompton & Harefield NHS Foundation Trust, Sydney Street, London SW3 6NP, England; and the National Heart and Lung Institute, Imperial College London, London, England (A.U.W., A.D., S.R.D.).
Sujal R DesaiFrom the Interstitial Lung Disease Unit (A.U.W.) and Department of Radiology (A.D., S.R.D.), Royal Brompton & Harefield NHS Foundation Trust, Sydney Street, London SW3 6NP, England; and the National Heart and Lung Institute, Imperial College London, London, England (A.U.W., A.D., S.R.D.).ORCID 0000-0002-5237-3613

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Lung Diseases, InterstitialFollow-Up StudiesHumansSARS-CoV-2Tomography, X-Ray Computed

Identifiers

PMID33502279
PMCPMC7841875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.